Aptose Biosciences Stock Analysis
| APS Stock | CAD 4.36 0.34 7.23% |
Aptose Biosciences is overvalued with Real Value of 2.85 and Hype Value of 3.88. The main objective of Aptose Biosciences stock analysis is to determine its intrinsic value, which is an estimate of what Aptose Biosciences is worth, separate from its market price. There are two main types of Aptose Biosciences' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Aptose Biosciences' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Aptose Biosciences' stock to identify patterns and trends that may indicate its future price movements.
The Aptose Biosciences stock is traded in Canada on Toronto Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. Aptose Biosciences is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, Boxing Day, New Year 's Day, Family Day, Good Friday, Victoria Day, Canada Day, Civic Holiday. Aptose Stock trading window is adjusted to America/Toronto timezone.
Aptose |
Aptose Stock Analysis Notes
The company recorded a loss per share of 125.61. Aptose Biosciences had not issued any dividends in recent years. The entity had 1:15 split on the 6th of June 2023. Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in the United States. Aptose Biosciences Inc. was founded in 1986 and is headquartered in Toronto, Canada. APTOSE BIOSCIENCES operates under Biotechnology classification in Canada and is traded on Toronto Stock Exchange. It employs 22 people. For more info on Aptose Biosciences please contact William Rice at 647 479 9828 or go to https://www.aptose.com.Aptose Biosciences Investment Alerts
| Aptose Biosciences is way too risky over 90 days horizon | |
| Aptose Biosciences appears to be risky and price may revert if volatility continues | |
| Aptose Biosciences has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (51.21 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Aptose Biosciences has accumulated about 36.37 M in cash with (44.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.64. | |
| Latest headline from news.google.com: Aptose Biosciences Inc. Short Interest Update - MarketBeat |
Aptose Largest EPS Surprises
Earnings surprises can significantly impact Aptose Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2022-08-02 | 2022-06-30 | -0.13 | -0.11 | 0.02 | 15 | ||
2020-03-10 | 2019-12-31 | -0.11 | -0.13 | -0.02 | 18 | ||
2019-03-12 | 2018-12-31 | -0.17 | -0.15 | 0.02 | 11 |
Aptose Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.35 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Aptose Biosciences's market, we take the total number of its shares issued and multiply it by Aptose Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Aptose Profitablity
Aptose Biosciences' profitability indicators refer to fundamental financial ratios that showcase Aptose Biosciences' ability to generate income relative to its revenue or operating costs. If, let's say, Aptose Biosciences is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Aptose Biosciences' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Aptose Biosciences' profitability requires more research than a typical breakdown of Aptose Biosciences' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (4.53) | (4.31) | |
| Return On Capital Employed | 20.67 | 21.70 | |
| Return On Assets | (4.53) | (4.31) | |
| Return On Equity | 15.89 | 16.68 |
Management Efficiency
Aptose Biosciences has return on total asset (ROA) of (1.4226) % which means that it has lost $1.4226 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (6.9413) %, meaning that it generated substantial loss on money invested by shareholders. Aptose Biosciences' management efficiency ratios could be used to measure how well Aptose Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Aptose Biosciences' Return On Capital Employed is very stable compared to the past year. As of the 1st of March 2025, Return On Equity is likely to grow to 16.68, though Return On Tangible Assets are likely to grow to (4.31). At this time, Aptose Biosciences' Total Assets are very stable compared to the past year. As of the 1st of March 2025, Non Current Assets Total is likely to grow to about 1.7 M, though Non Currrent Assets Other are likely to grow to (41.04).| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.49) | (0.47) | |
| Tangible Asset Value | 23.6 M | 21 M | |
| Tangible Book Value Per Share | (0.49) | (0.47) | |
| Enterprise Value Over EBITDA | (8.72) | (8.29) | |
| Price Book Value Ratio | (204.05) | (193.84) | |
| Enterprise Value Multiple | (8.72) | (8.29) | |
| Price Fair Value | (204.05) | (193.84) | |
| Enterprise Value | 16.1 M | 15.3 M |
Leadership effectiveness at Aptose Biosciences is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Technical Drivers
As of the 1st of March, Aptose Biosciences shows the Downside Deviation of 9.05, mean deviation of 88.37, and Risk Adjusted Performance of 0.1. Aptose Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Aptose Biosciences Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Aptose Biosciences middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Aptose Biosciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Aptose Biosciences Outstanding Bonds
Aptose Biosciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Aptose Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Aptose bonds can be classified according to their maturity, which is the date when Aptose Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Aptose Biosciences Predictive Daily Indicators
Aptose Biosciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Aptose Biosciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Aptose Biosciences Forecast Models
Aptose Biosciences' time-series forecasting models are one of many Aptose Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Aptose Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Aptose Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Aptose Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Aptose shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Aptose Biosciences. By using and applying Aptose Stock analysis, traders can create a robust methodology for identifying Aptose entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | 36.63 | 38.46 | |
| Operating Profit Margin | (38.56) | (40.48) | |
| Net Profit Margin | 36.63 | 38.46 | |
| Gross Profit Margin | 1.10 | 1.04 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Aptose Biosciences to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aptose Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Aptose Stock, please use our How to Invest in Aptose Biosciences guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.